Previous Close | 2.6920 |
Open | 2.6660 |
Bid | 2.7440 x N/A |
Ask | 2.8720 x N/A |
Day's Range | 2.6660 - 2.7680 |
52 Week Range | 2.5200 - 3.9200 |
Volume | |
Avg. Volume | 109 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for 4R0.SG
Asuragen, a Bio-Techne brand (NASDAQ: TECH) and Oxford Nanopore Technologies plc (Oxford Nanopore) (LSE: ONT), today announce a collaboration to develop assays designed to deliver more accurate and reliable options for reproductive health and carrier screening. Asuragen will leverage its gold-standard PCR technology with Oxford Nanopore's any-read-length DNA sequencing capabilities to develop the first sequencing system to identify the most challenging yet high prevalence carrier genes in a sing
Oxford Nanopore Technologies plc ( LON:ONT ) insiders who purchased shares in the last 12 months were richly rewarded...
Even the best stock pickers will make plenty of bad investments. Anyone who held Oxford Nanopore Technologies plc...